Read Time:6 Second
The Phase 2 trial was evaluating the vaccine called VLA15 following a second booster dose given one year after the first one.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
